New frontiers for the treatment of noncardiac chest pain: The adenosine receptors

American Journal of Gastroenterology

Volumn 102, Issue 5, 2007, Pages 939-941

  Achem, Sami R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CITALOPRAM; PLACEBO; PROTON PUMP INHIBITOR; SERTRALINE; STOMACH SECRETION INHIBITOR; TEGASEROD; THEOPHYLLINE;

ANALGESIC ACTIVITY; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TREATMENT FAILURE; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; NONCARDIAC CHEST PAIN; PH MEASUREMENT; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TERTIARY HEALTH CARE; TREATMENT DURATION; TREATMENT OUTCOME; VISCERAL PAIN;

BIOMECHANICS; CHEST PAIN; ESOPHAGEAL DISEASES; HUMANS; PHOSPHODIESTERASE INHIBITORS; RECEPTORS, PURINERGIC P1; RECURRENCE; THEOPHYLLINE;

EID: 34247860580     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01102.x     Document Type: Review

References (34)

1. Locke G 3rd, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmstead County, Minnesota. Gastroenterology 1997 112 : 1448 56.
2. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: Prevalence, risk factors, impact and consulting - a population-based study. Aliment Pharmacol Ther 2003 17 : 1115 24.
3. Chiocca JC, Olmos JA, Salis GB, et al. Prevalence, clinical spectrum and atypical symptoms of gastro-oesophageal reflux in Argentina: A nationwide population-based study. Aliment Pharmacol Ther 2005 22 : 331 42.
4. Wong WM, Lam KF, Cheng C, et al. Population based study of noncardiac chest pain in southern Chinese: Prevalence, psychosocial factors and health care utilization. World J Gastroenterol 2004 10 : 707 12.
5. Rey E, Elola-Olaso CM, Rodriguez-Artalejo F, et al. Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux in Spain. Eur J Gastroenterol Hepatol 2006 18 : 969 75.
6. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993 38 : 1569 80.
7. Richter JE, Bradley LA, Castell DO. Esophageal chest pain: Current controversies in pathogenesis, diagnosis and therapy. Ann Intern Med 1989 66 78.
8. Achem SR, DeVault KR. Recent developments in chest pain of undetermined origin. Curr Gastroenterol Rep 2000 2 : 201 9.
9. Van Handel D, Fass R. The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol 2005 20 (suppl S6 13.
10. Faybush EM, Fass R. Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am 2004 33 : 41 54.
11. Achem SR, Kolts BE, Wears R, et al. Chest pain associated with nutcracker esophagus: A preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol 1993 88 : 187 92.
12. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997 742 : 2138 45.
13. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998 115 : 42 9.
14. Bautista J, Fullerton H, Briseno M, et al. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2004 19 : 1123 30.
15. Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain? A meta-analysis. Arch Intern Med 2005 165 : 1222 8.
16. Cremonini F, Wise J, Moayyedi P, et al. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis. Am J Gastroenterol 2005 100 : 1226 32.
17. Wong WM, Beeler J, Risner-Adler S, et al. Attitudes and referral patterns of primary care physicians when evaluating subjects with noncardiac chest pain - a national survey. Dig Dis Sci 2005 50 : 656 61.
18. Achem SR, Ferguson DD, Hugl B, et al. Persistent non-cardiac chest pain in patients on PPI therapy: Prevalence, prescribing patterns and results of pH testing at a tertiary referral center. Am J Gastroenterol 2005 100 : S38.
19. Rao SC, Mudipalli RS, Remes-Troche JM, et al. Theophylline improves esophageal chest pain - a randomized, placebo controlled study. Am J Gastroenterol 2007.
20. Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. Double-blind, placebo-controlled trial. Gastroenterology 1987 92 : 1027 36.
21. Cannon RO 3rd., Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994 20 : 1411 7.
22. Varia I, Logue E, O'Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000 140 : 367 72.
23. Broekaert D, Fischler B, Sifrin D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on esophageal hypersensitivity: A double-blind, placebo-controlled study. Aliment Pharmacol Ther 2006 23 : 365 70.
24. Rodriguez-Stanley S, Zubaidi S, Proskin HM, et al. Effect of tegaserod on esophageal pain threshold, regurgitation and symptom relief in patients with functional heartburn and mechanical sensitivity. Clin Gastroenterol Hepatol 2006 4 : 442 50.
25. Achem SR. Chest pain and serotonin: A possible link? Gastroenterology 2001 121 : 495 6.
26. Moro S, Gao ZG, Jacobson KA, et al. Progress in the pursuit of therapeutic adenosine receptor antagonists. Med Res Rev 2006 26 : 131 59.
27. Johansson B, Halldner L, Donwiddie TV, et al. Hyperalgesia, anxiety and decreased hypoxic neuroprotection in mice lacking the Adenosine A1 receptor. Proc Natl Acad Sci U S A 2001 98 : 9407 12.
28. Wu WP, Has JX, Halldner L, et al. Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain 2005 113 : 395 404.
29. Sylven C, Beerman B, Jonzon B, et al. Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers. Br Med J 1996 293 : 227 30.
30. Niewoehner DE. Theophylline therapy. A continuing dilemma. Chest 1990 98 : 5.
31. Jacobson KA, Gao Z-G. Adeonsine receptors as therapeutic agents. Nature 2006 5 : 247 64.
32. Giffin NJ, Kowacs F, Libri V, et al. Effect of adenosine A1 receptor agnonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 2003 23 : 287 92.
33. Zambbrowicz BP, Turner CA, Sands AT. Predicting drug efficacy: Knockouts model pipeline drugs on the pharmaceutical industry. Curr Opin Pharmacol 2003 3 : 563 70.
34. Li X, Conklin D, Pan HL, et al. Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism. J Pharmacol Exp Ther 2003 305 : 950 5.